Neuroinflammation, COX-2, and ALS - a dual role?

被引:137
作者
Consilvio, C [1 ]
Vincent, AM [1 ]
Feldman, EL [1 ]
机构
[1] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA
关键词
neuroinflammation; COX-2; ALS;
D O I
10.1016/j.expneurol.2003.12.009
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Although the root cause of many neurodegenerative diseases is unknown, neuroinflammation may play a key role in these types of disease, including amyotrophic lateral sclerosis (ALS). In the context of neurodegeneration, it is unclear if the disease is propagated through inflammation, or whether in contrast, evidence of inflammation reflects an attempt to protect against further cellular injury. Inflammatory pathways involving the cyclooxygenase (COX) enzymes and subsequent generation of prostaglandins are potential target sites for treatments to halt the progression of ALS. In the CNS, COX enzymes are localized to neurons, astrocytes, and microglia and can be induced under various conditions. In addition, there appears to be a dual role for the prostaglandin products of COX enzymes in the nervous system. Some prostaglandins promote the survival of neurons, while others promote apoptosis. In this review, the pathways of COX activity and prostaglandin production form the center of the debate regarding the dual nature of neuroinflammation. We will also discuss how this duality may affect future treatments for neurodegenerative diseases such as ALS. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:1 / 10
页数:10
相关论文
共 86 条
  • [1] Adams J, 1996, J NEUROCHEM, V66, P6
  • [2] PROSTAGLANDIN E(2) PROTECTS CULTURED CORTICAL-NEURONS AGAINST N-METHYL-D-ASPARTATE RECEPTOR-MEDIATED GLUTAMATE CYTOTOXICITY
    AKAIKE, A
    KANEKO, S
    TAMURA, Y
    NAKATA, N
    SHIOMI, H
    USHIKUBI, F
    NARUMIYA, S
    [J]. BRAIN RESEARCH, 1994, 663 (02) : 237 - 243
  • [3] Inflammation and Alzheimer's disease
    Akiyama, H
    Barger, S
    Barnum, S
    Bradt, B
    Bauer, J
    Cole, GM
    Cooper, NR
    Eikelenboom, P
    Emmerling, M
    Fiebich, BL
    Finch, CE
    Frautschy, S
    Griffin, WST
    Hampel, H
    Hull, M
    Landreth, G
    Lue, LF
    Mrak, R
    Mackenzie, IR
    McGeer, PL
    O'Banion, MK
    Pachter, J
    Pasinetti, G
    Plata-Salaman, C
    Rogers, J
    Rydel, R
    Shen, Y
    Streit, W
    Strohmeyer, R
    Tooyoma, I
    Van Muiswinkel, FL
    Veerhuis, R
    Walker, D
    Webster, S
    Wegrzyniak, B
    Wenk, G
    Wyss-Coray, T
    [J]. NEUROBIOLOGY OF AGING, 2000, 21 (03) : 383 - 421
  • [4] Increased levels of the pro-inflammatory prostaglandin PGE2 in CSF from ALS patients
    Almer, G
    Teismann, P
    Stevic, Z
    Halaschek-Wiener, J
    Deecke, L
    Kostic, V
    Przedborski, S
    [J]. NEUROLOGY, 2002, 58 (08) : 1277 - 1279
  • [5] Almer G, 2001, ANN NEUROL, V49, P176, DOI 10.1002/1531-8249(20010201)49:2<176::AID-ANA37>3.3.CO
  • [6] 2-O
  • [7] The NF-kappa B and I kappa B proteins: New discoveries and insights
    Baldwin, AS
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 : 649 - 683
  • [8] Beneficial effects of lysine acetylsalicylate, a soluble salt of aspirin, on motor performance in a transgenic model of amyotrophic lateral sclerosis
    Barnéoud, P
    Curet, O
    [J]. EXPERIMENTAL NEUROLOGY, 1999, 155 (02) : 243 - 251
  • [9] Expression and regulation of cyclooxygenase-2 in rat microglia
    Bauer, MKA
    Lieb, K
    SchulzeOsthoff, K
    Berger, M
    GebickeHaerter, PJ
    Bauer, J
    Fiebich, BL
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 243 (03): : 726 - 731
  • [10] Prostaglandins stimulate calcium-dependent glutamate release in astrocytes
    Bezzi, P
    Carmignoto, G
    Pasti, L
    Vesce, S
    Rossi, D
    Rizzini, BL
    Pozzan, T
    Volterra, A
    [J]. NATURE, 1998, 391 (6664) : 281 - 285